STOCKHOLM, SWEDEN November 4, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has received regulatory approval to initiate the ...

Pociredir Phase 1b PIONEER Trial Data in Sickle Cell Disease to be Presented and Published, Including 12 mg and 20 mg Cohorts ―― Live and ...

An update from Karolinska Development AB ( ($SE:KDEV) ) is now available. Karolinska Development’s portfolio company, Modus Therapeutics, has ...

Q3 2025 Earnings Call Transcript November 3, 2025 Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS ...

Calcium and iron supplements can interact with each other. Taking them at different times of the day may be necessary to ...

Baystreet.ca News Commentary – The global biologics industry is experiencing unprecedented expansion as the market surges ...

Scott Adams, creator of Dilbert, pleaded with President Donald Trump for help after his cancer diagnosis, Kennedy responded.

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

Abcuro, Inc., a late-stage clinical biotechnology company developing potential first-in-class immunotherapies for the benefit of people living with debilitating and progressive rare autoimmune ...

For Jane, a failed breathalyzer and a DUI charge despite being sober were not a mistake, but a symptom of a rare medical ...

Vitamin C enhances iron absorption, and taking vitamin C with some other nutrients may help enhance the effects of each.

Recordati Rare Diseases Inc. today announced the presentation of new data related to its growing portfolio of treatments for rare hematologic disorders at the 67th American Society of Hematology (ASH) ...